Histologic follow-up in patients with papanicolaou test findings of endometrial cells: Results from a large Academic Women's Hospital Laboratory

American Journal of Clinical Pathology

Volumn 138, Issue 1, 2012, Pages 79-84

  Li, Zaibo ^a   Gilbert, Christopher ^a   Yang, Huaitao ^a   Zhao, Chengquan ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Atypical endometrial cells; Endometrial cancer; Endometrial precancerous lesion; Normal endometrial cells; Papanicolaou test

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER CELL; ENDOMETRIUM CANCER; ENDOMETRIUM CELL; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; PAPANICOLAOU TEST; POSTMENOPAUSE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; FOLLOW-UP STUDIES; HUMANS; LABORATORIES, HOSPITAL; MENSTRUAL CYCLE; MIDDLE AGED; POSTMENOPAUSE; RETROSPECTIVE STUDIES; VAGINAL SMEARS;

EID: 84864223315     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCP07DCKKZFKSDL     Document Type: Article

References (38)

1. Jemal A, Thomas A, Murray T, et al. Cancer statistics, 2002. CA Cancer J Clin. 2002;52:23-47. (Pubitemid 34110469)
2. Burk JR, Lehman HF, Wolf FS. Inadequacy of Papanicolaou smears in the detection of endometrial cancer. N Engl J Med. 1974;291:191-192.
3. Ng AB, Reagan JW, Hawliczek S, et al. Significance of endometrial cells in the detection of endometrial carcinoma and its precursors. Acta Cytol. 1974;18:356-361.
4. Gondos B, King EB. Significance of endometrial cells in cervicovaginal smears. Ann Clin Lab Sci. 1977;7:486-490. (Pubitemid 8227720)
5. Gusberg SB, Milano C. Detection of endometrial cancer and its precursors. Cancer. 1981;47(5 suppl):1173-1175. (Pubitemid 11159591)
6. Ng AB. The cellular detection of endometrial carcinoma and its precursors. Gynecol Oncol. 1974;2:162-719.
7. Papillo JL. Who is teaching teens about HPV? Diagn Cytopathol. 2002;26:128-129. (Pubitemid 34113137)
8. Bean SM, Connolly K, Roberson J, et al. Incidence and clinical significance of morphologically benign-appearing endometrial cells in patients age 40 years or older: the impact of the 2001 Bethesda System. Cancer. 2006;108:39-44. (Pubitemid 43291242)
9. Thrall MJ, Kjeldahl KS, Savik K, et al. Significance of benign endometrial cells in Papanicolaou tests from women aged ≥40 years. Cancer. 2005;105:207-216. (Pubitemid 41177000)
10. Mitchell H, Giles G, Medley G. Accuracy and survival benefit of cytological prediction of endometrial carcinoma on routine cervical smears. Int J Gynecol Pathol. 1993;12:34-40. (Pubitemid 23013909)
11. Mitchell H, Hocking J, Saville M. Improvement in protection against adenocarcinoma of the cervix resulting from participation in cervical screening. Cancer. 2003;99:336-341. (Pubitemid 38017531)
12. Andrae B, Kemetli L, Sparen P, et al. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst. 2008;100:622-629.
13. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287:2114-2119. (Pubitemid 34437346)
14. US Census Bureau American Community Survey. http://www.census.gov/acs/ www/. Accessed December 1, 2008.
15. Dzura B, Quinn S, Richard K. Performance of an imaging system vs manual screening in the detection of squamous intraepithelial lesions of the cervix. Acta Cytol. 2006;50:309-311. (Pubitemid 43837043)
16. Wu HH, Schuetz MJ, Cramer H. Significance of benign endometrial cells in Pap smears from postmenopausal women. J Reprod Med. 2001;46:795-798. (Pubitemid 32924252)
17. Montz FJ. Significance of "normal" endometrial cells in cervical cytology from asymptomatic postmenopausal women receiving hormone replacement therapy. Gynecol Oncol. 2001;81:33-39. (Pubitemid 32368074)
18. Brogi E, Tambouret R, Bell DA. Classification of benign endometrial glandular cells in cervical smears from postmenopausal women. Cancer. 2002;96:60-66. (Pubitemid 34438645)
19. Ng AB, Reagan JW, Cechner RL. The precursors of endometrial cancer: a study of their cellular manifestations. Acta Cytol. 1973;17:437-448.
20. DuBeshter B, Warshal DP, Angel C, et al. Endometrial carcinoma: the relevance of cervical cytology. Obstet Gynecol. 1991;77:458-462.
21. Eddy GL, Wojtowycz MA, Priaino PS, et al. Papanicolaou smears by the Bethesda System in endometrial malignancy: utility and prognostic importance. Obstet Gynecol. 1997;90:999-1003. (Pubitemid 27510145)
22. Demirkiran F, Arvas M, Erkun E, et al. The prognostic significance of cervico-vaginal cytology in endometrial cancer. Eur J Gynaecol Oncol. 1995;16:403-409.
23. Gu M, Shi W, Barakat R, et al. Pap smears in women with endometrial carcinoma. Acta Cytol. 2001;45:555-560. (Pubitemid 32674893)
24. Karim BO, Burroughs FH, Rosenthal DL, et al. Endometrial-type cells in cervico-vaginal smears: clinical significance and cytopathologic correlates. Diagn Cytopathol. 2002;26:123-127. (Pubitemid 34113136)
25. Kapali M, Agaram NP, Dabbs D, et al. Routine endometrial sampling of asymptomatic premenopausal women shedding normal endometrial cells in Papanicolaou tests is not cost effective. Cancer. 2007;111:26-33. (Pubitemid 46281081)
26. Saad RS, Mahdavy M, Takei H, et al. Endometrial cells in cervical specimens of women >40 years of age [abstract]. Acta Cytol. 2004;48:678-679.
27. Ely KA, Bregman S, Arnott CK. Clinical significance of reporting endometrial cells in patients over the age of 40 and its influence on the decision to biopsy [abstract]. Acta Cytol. 2004;48:678.
28. Long KD, Biscotti C. An analysis of the Bethesda System 2001 guideline for reporting benign endometrial cells [abstract]. Acta Cytol. 2004;48:676-677.
29. Papillo JC, Harmon ML, Mount SL, et al. Reporting of endometrial cells in women 40-50 results in increased endometrial biopsies with low yield [abstract]. Acta Cytol. 2004;48:677-678.
30. Simsir A, Carter W, Elgert P, et al. Reporting endometrial cells in women 40 years and older: assessing the clinical usefulness of Bethesda 2001. Am J Clin Pathol. 2005;123:571-575. (Pubitemid 40418552)
31. Gomez-Fernandez CR, Ganjei-Azar P, Capote-Dishaw J, et al. Reporting normal endometrial cells in Pap smears: an outcome appraisal. Gynecol Oncol. 1999;74:381-384. (Pubitemid 29439877)
32. Kerpsack JT, Finan MA, Kline RC. Correlation between endometrial cells on Papanicolaou smear and endometrial carcinoma. South Med J. 1998;91:749-752. (Pubitemid 28374527)
33. Cherkis RC, Patten SF Jr, Dickinson JC, et al. Significance of atypical endometrial cells detected by cervical cytology. Obstet Gynecol. 1987;69:786-789. (Pubitemid 17057843)
34. Van den Bosch T, Vandendael A, Wranz PA, et al. Cervical cytology in menopausal women at high risk for endometrial disease. Eur J Cancer Prev. 1998;7:149-152. (Pubitemid 28206766)
35. Zhao C, Austin RM, Pan J, et al. Clinical significance of atypical glandular cells in conventional Pap smears in a large, high-risk US West Coast minority population. Acta Cytol. 2009;53:153-159.
36. Zhao C, Florea A, Onisko A, et al. Histologic follow-up results in 662 patients with Pap test findings of atypical glandular cells: results from a large academic womens hospital laboratory employing sensitive screening methods. Gynecol Oncol. 2009;114:383-389.
37. Fadare O, Ghofrani M, Chacho MS, et al. The significance of benign endometrial cells in cervicovaginal smears. Adv Anat Pathol. 2005;12:274-287. (Pubitemid 41463809)
38. Greenspan DL, Cardillo M, Davey DD, et al. Endometrial cells in cervical cytology: review of cytological features and clinical assessment. J Low Genit Tract Dis. 2006;10:111-122. (Pubitemid 44259034)